Exhibit 10.1
PRODUCT SUPPLY &
DISTRIBUTION AGREEMENT
This PRODUCT SUPPLY &
DISTRIBUTION AGREEMENT (“Agreement”), made as of this
27th day of July, 2004 (“Effective Date”), by and
between SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (hereinafter,
referred to as “Schering”), a Delaware corporation,
having its principal office located at 1095 Morris Avenue, Union,
New Jersey 07083, and DIGITAL ANGEL CORPORATION (hereinafter,
referred to as “Digital Angel”), a Delaware
corporation, having its principal office located at 490 Villaume
Avenue, South St. Paul, Minnesota 55075-2445.
RECITALS
WHEREAS, on January 9, 1995,
Schering entered into that Supply and Distribution Agreement (the
“Original Agreement”) with Destron Fearing Corporation
(“Destron”), predecessor-in-interest to Digital Angel,
for Destron to supply to Schering, and Schering to purchase from
Destron, certain animal electronic identification
products;
WHEREAS, Digital Angel is now
engaged in the business of developing, manufacturing, packaging,
testing and selling microchips for tracking and identifying, and
sensing temperature in, pets and other animals as more fully
described below (the “Product”);
WHEREAS, Schering desires to
purchase and receive the Product from Digital Angel, and the
exclusive right to distribute the Product in the Territory (as
hereinafter defined);
WHEREAS, Digital Angel agrees to
sell and deliver the Product to Schering on the terms and
conditions set forth in this Agreement;
WHEREAS, Digital Angel has the
requisite experience and resources to sell and deliver the Product
in a quantity required for the Territory; and
WHEREAS, the Parties have agreed to
enter into this Agreement, which supersedes and replaces in its
entirety the Original Agreement referred to above.
NOW, THEREFORE, in consideration of
the premises and the mutual agreements and covenants set forth in
this Agreement, Schering and Digital Angel hereby agree as
follows:
ARTICLE I.
DEFINITIONS
For purposes of this Agreement, the
following terms shall have the following meanings (such meanings to
be equally applicable to both the singular and plural forms of the
terms defined):
1.01
“Adverse Event” shall
mean:
(a)
any expected or unexpected
experience that is adverse, including what are commonly described
as adverse or undesirable experiences, adverse events, adverse
reactions, side effects, or death due to any cause associated with,
or observed in conjunction with, the use or
following the administration of any Product,
whether or not (i) considered related to or caused by the use
of any Product, (ii) occurred in the course of the use of any
Product, (iii) occurred when the Product was used in
accordance with the approved labelling or label directions or was
not used in accordance with such labelling or directions (including
a different route of administration, different species, different
indications, or different dosage), or (iv) associated with, or
observed in conjunction with, an accidental or intentional
overdose, abuse, dependency, or withdrawal from, of, or on any
Products, including, without limitation, an adverse event occurring
(A) in animals in the course of use of any Product by a
veterinarian or livestock producer or otherwise in the course of
professional practice or use by another animal owner or caretaker
or (B) in humans from exposure during Manufacture, testing,
handling, or use of a Product;
(b)
any failure of expected
pharmacological action or clinical effect of any Products,
including, without limitation, deterioration or contamination of
any Products or any mistake in the labelling of any Products;
or
(c)
an adverse drug experience, as that
term is defined in 21 C.F.R. § 514.3.
1.02
“Affiliate” shall mean
any entity, directly or indirectly, controlling, controlled by, or
under common control with a Party. For purposes of this
definition, “controlling” (including its cognates,
“controlled by” and “under common control”)
shall mean: (a) ownership of more than fifty percent (50%) of
the equity capital or other ownership interest in or of an entity;
(b) the power to control or otherwise direct the affairs of an
entity; (c) in the case of non-stock organizations, the power to
control the distribution of profits of an entity; or (d) such other
relationship as, in fact, results in actual control over the
management, business, and affairs of an entity.
1.03
“Agent” shall mean any
officer, director, employee, agent, subcontractor, or other
authorized representatives of a Party or a Person.
1.04
“Applicable Laws” shall
mean (a) all laws, statutes, constitutions, treaties, rules,
regulations, ordinances, codes, guidance, common law, and (b) all
judicial, executive, legislative, administrative or military
orders, directives, decrees, injunctions, judgments, Permits,
agreements, and other legal requirements of, with, or adopted or
imposed by any Governmental Authority, now or hereafter in effect
and, in each case, as amended from time to time, including, without
limitation, any such legal requirements that relate to or govern
(i) the manufacture or quality of the Product, (ii) health, safety,
industrial hygiene, sanitation, or (iii) conditions on, under,
about, or affecting any real property (including the
Environment).
1.05
“Approved Facility”
shall mean Digital Angel’s facility located in 490 Villaume
Street, South St. Paul, Minnesota 55075-2445.
1.06
“Certificate” shall have
the meaning set forth in Section 3.06(c) hereof.
1.07
“Claim” shall mean any
claim, suit, action, cause of action, proceeding, demand, order,
directive, obligation, loss, injury, liability, damage, deficiency,
assessment, fine, penalty, forfeiture, judgment, lien, diminution
of value, notice of violation or non-compliance, cost, and expense,
including, without limitation, attorneys’ fees and expenses,
incurred to enforce this Agreement, cost of defense, and cost of
settlement.
2
1.08
“Companion Animal
Market” shall mean all domestic animals kept as pets except
horses, cattle, swine and sheep.
1.09
“Confidential
Information” shall mean any technical, financial and business
information relating to a Party’s research, development,
inventions, products (including the Products), production,
manufacturing, finances, marketing, customers, or business plans,
including, without limitation, trade secrets, know-how, data,
formulas, processes, other intellectual property, or confidential
communications, that (a) is or has been disclosed to or otherwise
received or obtained by a Receiving Party, whether or not in
connection with or pursuant to this Agreement and (b) has been
marked by the Disclosing Party as “Confidential” or, if
disclosed orally, has been stated to be confidential or has been
confirmed in writing by the Disclosing Party to be
“Confidential” within thirty (30) days from the date of
such disclosure.
1.10
“Database” shall mean
for the companion animal market the list of pet owners, their
addresses and the serial number on the Product sold to such pet
owner set forth in the centralized, computerized database developed
and used by Schering in connection with the Product and the
System.
1.11
“Disclosing Party” shall
mean the Party (a) who discloses, and owns or otherwise possesses
the rights or interests to or in, Confidential Information or (b)
whose Confidential Information is the subject of any process,
subpoena, demand, or request.
1.12
“Effective Date” shall
have the meaning set forth in the introductory paragraph to this
Agreement.
1.13
“Enrollment Fee” shall
mean the fee that a customer pays to Schering or its designated
agent for tracking and identification services related to the
Product.
1.14
“Environment” shall mean
air, land, water, the ocean, natural resources (including flora and
fauna), soil, sediments, surface water, groundwater, subsurface
strata, the ambient air, or any present or potential drinking water
supply, including, without limitation, any of the foregoing
relating to the manufacture of any Product or the processing, use,
generation, handling, labelling, transportation, treatment,
storage, disposal, disposition, distribution, presence, emission,
discharge, release, threatened release, removal, remediation,
disclosure, or notice of the actual or potential presence, release,
or threatened release of any Hazardous Material.
1.15
“Environmental Claim”
shall mean any and all Claims (a) relating in any way to the
Environment under Applicable Law or (b) made by any Person for
enforcement (including, without limitation, fines, penalties,
costs, damages, specific work, or relief), investigation, cleanup,
mitigation, restoration, removal, response, remedial or other
actions or damages (including by reason of personal injury,
property damage, or death), contribution, indemnification, cost
recovery, compensation, or injunctive relief pursuant to any
Applicable Law or relating, directly or indirectly, to the
Environment or Hazardous Material.
1.16
“Governmental Authority”
shall mean any federal, state, commonwealth, provincial, local or
foreign governmental authority, entity, body, branch, agency,
department, bureau, board, commission, officer, official, court,
adjudicator, tribunal, or other entity, including
3
any Agent thereof, exercising executive,
legislative, judicial, regulatory or administrative authority over
the manufacture, marketing, pricing, use, or sale of any Product,
including, without limitation, any and all state, commonwealth,
provincial, local and foreign equivalents.
1.17
“Hazardous Material”
shall mean any material, substance, or waste that, because of its
presence, quantity, concentration, or character, (a) is
regulated under any Applicable Law, (b) may cause or pose a
risk, threat, or hazard to human health or safety or the
Environment, or (c) may result in the imposition of, or form
the basis for, a Claim from or by any Person under any Applicable
Law, including any investigation, cleanup, removal, or remedial or
other action of or concerning the Environment or any of the
following: (i) any “hazardous substance,”
“pollutant,” “contaminant,” or
“hazardous waste,” as commonly understood and as
defined in any Applicable Law, (ii) any substance containing
petroleum, or any by-product or fraction thereof, any form of
natural gas, mining waste, lead, asbestos-containing material,
polychlorinated biphenyls, equipment containing polychlorinated
biphenyls, pesticides, defoliants, and urea formaldehyde foam
insulation, (iii) any radioactive material or waste, or
(iv) any other dangerous, explosive, corrosive, ignitable,
flammable, hazardous, pathogenic, mutagenic, carcinogenic,
teratogenic, etiologic or otherwise toxic agent, material,
contaminant, substance, element, compound, mixture, solution,
pollutant, or waste, including, without limitation, asbestos and
radioactive substances regulated by any Applicable Law.
1.18
“Improved Product” means
any new, novel and useful ideas, innovations and inventions solely
for use in the Companion Animal Market, whether patentable or not,
which are discovered by Digital Angel or are otherwise made
available to Digital Angel during, or as a result of, or occurring
in connection with, or arising from, this Agreement that adds
significant new functions and capabilities to the Product and/or
either Reader.
1.19
“Intellectual Property
Rights” means, collectively, all of the following worldwide
intangible legal rights, whether or not filed, perfected,
registered or recorded and whether now or hereafter existing,
filed, issued or acquired: (a) patents, patent disclosures, patent
rights, including any and all continuations, continuations-in-part,
divisionals, reissues, reexaminations, utility, model and design
patents or any extensions thereof, (b) rights associated with works
of authorship, including without limitation, copyrights, copyright
applications and copyright registrations, (c) rights in trademarks,
trademark registrations and applications therefor, trade names,
service marks, service names, logos, or trade dress, (d) rights
relating to the protection of trade secrets and confidential
information, and (e) all other intellectual or proprietary rights
anywhere in the world.
1.20
“Party” shall mean
Schering or Digital Angel; “Parties” shall mean
Schering and Digital Angel.
1.21
“Patent Rights” shall
mean U.S. Patent No. 5,211,129, U.S. Patent No. 4,730,188, U.S.
Patent No. 5,041,826 and U.S. Patent No. 5,166,676 and any and all
patents and patent applications (including certificates of
invention and applications for certificates of invention) over the
Products, including any and all divisions, continuations,
continuations-in-part, patents of addition, reissues, renewals,
extensions, registrations, confirmations, re-examinations, any
provisional applications, supplementary protection certificates, or
the like of any such patents and
4
patent applications, which during the Term are
owned by Digital Angel or to which Digital Angel, through license
or otherwise, has or acquires rights.
1.22
“Permit” shall mean
every application (including new animal drug application) permit,
authorization, license, approval, registration (including health
registration and drug master file), franchise, certificate,
permission, exemption, consent, variance (including zoning variance
approval), or equivalent decision or document of, from, or required
or issued by any Governmental Authority or under any Applicable
Laws.
1.23
“Person” shall mean and
include, without limitation, (a) any corporation, partnership,
limited liability company, joint venture, joint stock company,
association, trust, business trust, estate, unincorporated
organization, or other business entity recognized under Applicable
Laws, other than Schering or Digital Angel, (b) any Governmental
Authority, or (c) any individual.
1.24
“Product” shall mean
Digital Angel’s animal identification package which includes
the following components:
(a)
Temperature Sensing Product;
or
(b)
Shelter Product; and
(c)
Recording forms and tags for the Database and System described
herein
The Product shall include upgraded microchip
technology necessary to meet applicable standards, including but
not limited to Federation of European Companion Animal Veterinary
Associations (“FECAVA”) technology standards. The term
“Product” as used in this Agreement, including
“Improved Product”, shall, in all cases, refer only to,
and only permit use in the Companion Animal Market.
1.25
“Product Cost” shall
have the meaning set forth in Section 6.01 hereof.
1.26
“Product Quality
Complaint” shall have the meaning set forth in
Section 3.07 (b) (i).
1.27
“Readers” shall mean
instruments that are capable of reading and displaying the
identification code of Digital Angel’s transponders and other
transponders using Eurosil microchips, and all other transponders
meeting current and future FECAVA transponder standards to be used
in the System. Readers shall include Pocket Readers for
veterinary clinics and Pocket Readers EX for shelters.
1.28
“Receiving Party” shall
mean the Party who (a) receives or otherwise obtains Confidential
Information of the Disclosing Party or (b) is served with any
process, subpoena or demand.
1.29
“Shelter Product” shall
mean an injectable sterile glass encapsulated radio frequency
transponder with an anti-migration cap, preloaded in a sterilized
needle and application used to deposit the transponder
subcutaneously.
5
1.30
“Specifications” shall
mean the written specifications for the manufacture, quality
control testing, and delivery of the Product, including, without
limitation, details of the finished packaging components for the
Product, as set forth on Exhibit A, which is attached hereto and
made a part hereof, and as may be amended from time to
time.
1.31
“System” shall mean the
nationwide animal registry, identification, tracking and recovery
system, comprised of the Product and the Database, developed and
used by Schering in connection with this Agreement.
1.32
“Temperature Sensing
Product” shall mean an injectable sterilized glass
encapsulated radio frequency transponder with an anti-migration
cap, preloaded in a sterilized needle and application used to
deposit the transponder subcutaneously which includes temperature
sensing capabilities.
1.33
“Term” shall have the
meaning set forth in Section 10.01 hereof.
1.34
“Territory” shall mean
the United States and its possessions and territories.
1.35
“Third Party” shall mean
and include, without limitation, any individual, corporation,
partnership, limited liability company, joint venture, joint stock
company, association, trust, business trust, estate, unincorporated
organization, or other business entity recognized under Applicable
Laws, other than Schering or Digital Angel.
1.36
“Trademarks” shall have
the meaning set forth in Section 7.01 hereof.
ARTICLE II.
REPRESENTATIONS AND WARRANTIES
2.01
Representations of
Schering . Schering
hereby represents and warrants to Digital Angel that, as of the
Effective Date, the following statements are and shall be true and
correct in all material respects:
(a)
Organization and Good
Standing .
Schering: (i) is a corporation duly organized, validly existing,
and in good standing under the laws of the State of Delaware; (ii)
has the corporate power and authority to conduct the business in
which it presently is engaged, to enter into this Agreement, and to
perform its obligations hereunder; and (iii) is qualified to do
business in, and is in good standing in, each jurisdiction of the
Territory where the nature of its business in such jurisdiction
requires it to be so qualified.
(b)
Authorization and Binding
Effect . All
institutional action on the part of Schering and its officers and
directors necessary for the authorization, execution, and delivery
of this Agreement and for the performance of all of
Schering’s obligations hereunder has been taken, and this
Agreement, when executed and delivered, shall constitute a legal,
valid and binding obligation of Schering enforceable against
Schering in accordance with this Agreement’s terms, except as
enforceability may be limited by bankruptcy, insolvency, and other
laws affecting creditors’ rights generally or by general
equitable principles.
6
(c)
Execution, Delivery and
Performance . The
execution, delivery, and performance by Schering of this Agreement
do not: (i) violate or breach the certificate of
incorporation, articles of association, bylaws, or other
constituent documents of Schering; (ii) violate or conflict with
any Applicable Laws; (iii) violate, breach, cause a default under,
or otherwise give rise to a right of termination, cancellation, or
acceleration with respect to (presently, with the giving of notice,
or with the passage of time) any agreement, contract, or instrument
to which Schering is a party or by which any of its assets are
bound; or (iv) result in the creation or imposition of any lien,
pledge, mortgage, claim, charge, or encumbrance upon any assets of
Schering.
(d)
Governmental and Other
Consents . No
Permit or approval of, or exemption or other action by, any Person
is required in connection with Schering’s execution and
delivery of this Agreement or with the performance by Schering of
its obligations hereunder.
(e)
Inconsistent
Obligations .
Schering has no obligation or commitment, and will not, during the
Term, assume or undertake any obligation or commitment, that is
inconsistent with its obligations under, or the terms and
conditions of, this Agreement.
2.02
Representations of Digital
Angel . Digital
Angel hereby represents and warrants to Schering that, as of the
Effective Date, the following statements are and shall be true and
correct in all material respects:
(a)
Organization and Good
Standing . Digital
Angel: (i) is a corporation or other entity duly organized,
validly existing, and in good standing under the laws of Delaware;
(ii) has the corporate or institutional power and authority to
conduct the business in which it presently is engaged, to enter
into this Agreement, and to perform its obligations hereunder; and
(iii) is qualified to do business in, and is in good standing in,
each jurisdiction of the Territory where the nature of its business
in such jurisdiction requires it to be so qualified.
(b)
Authorization and Binding
Effect . All
institutional action on the part of Digital Angel and its officers
and directors necessary for the authorization, execution, and
delivery of this Agreement and for the performance of all of
Digital Angel’s obligations hereunder has been taken, and
this Agreement, when executed and delivered, shall constitute a
legal, valid and binding obligation of Digital Angel enforceable
against Digital Angel in accordance with this Agreement’s
terms, except as enforceability may be limited by bankruptcy,
insolvency, and other laws affecting creditors’ rights
generally or by general equitable principles.
(c)
Execution, Delivery and
Performance . The
execution, delivery, and performance by Digital Angel of this
Agreement do not: (i) violate or breach the certificate of
incorporation, articles of association, bylaws, or other
constituent documents of Digital Angel; (ii) violate or conflict
with any Applicable Laws; (iii) violate, breach, cause a default
under, or otherwise give rise to a right of termination,
cancellation, or acceleration with respect to (presently, with the
giving of notice, or with the passage of time) any agreement,
contract, or instrument to which Digital Angel is a party or by
which any of its assets are bound; or (iv) result in the creation
or imposition of any lien, pledge, mortgage, claim, charge, or
encumbrance upon any assets of Digital Angel.
7
(d)
Governmental and Other
Consents . No
Permit or approval of, or exemption or other action by, any Person
is, or will be, required in connection with Digital Angel’s
execution and delivery of this Agreement or with the performance by
Digital Angel of its obligations hereunder.
(e)
Inconsistent
Obligations .
Digital Angel has no obligation or commitment, and will not, during
the Term, assume or undertake any obligation or commitment, that is
inconsistent with its obligations under, or the terms and
conditions of, this Agreement.
(f)
Ownership and
Non-Infringement .
Digital Angel owns all right, title and interest in and to and/or
licenses the Intellectual Property Rights contained in the
Product. The Product does not infringe, misappropriate or
violate any Intellectual Property Rights of any third party.
As of the date of this Agreement, Digital Angel has no knowledge of
any pending or threatened litigation or claim relating to the
Product or any Intellectual Property Rights or materials contained
therein.
(g)
Debarment . Digital Angel (i) has not been
debarred pursuant to Section 306 of the Federal Food, Drug,
and Cosmetic Act, 21 U.S.C. § 335a, (ii) is not
subject to debarment, (iii) will not use, in any capacity in
connection with the services to be performed under this Agreement,
any Person who has been so debarred or is the subject of a
conviction described in such section, and (iv) will notify
Schering immediately if (A) Digital Angel or any Person who is
performing services hereunder is debarred or is the subject of a
conviction described in such section or (B) any action,
suit, claim, investigation, or legal or administrative proceeding
is pending or, to the best of Digital Angel’s knowledge, is
threatened, relating to the debarment or conviction of Digital
Angel or any Person performing services hereunder.
ARTICLE III.
PRODUCT AND QUANTITY
3.01
Scope of Agreement
. During the Term, Digital Angel
shall exclusively manufacture, supply, and sell to Schering, and
Schering shall exclusively purchase from Digital Angel, such
quantities of the Product as Schering may, from time to time,
elect. Digital Angel shall not manufacture, supply or sell
the Product to any other Person in the Territory. Digital
Angel hereby grants Schering an exclusive right to use the Product
in the companion animal market for sale in the Territory, using
Digital Angel’s Intellectual Property Rights relating to the
Product or its manufacture. Schering shall have the right to
grant sublicenses in connection with its sale of the Product in the
Territory. To the extent permitted by Applicable Law and
subject to the terms of this Agreement, the term
“exclusive” referred to in this Article 3 means
that Digital Angel shall not itself sell, or appoint another
distributor to sell, the Product in the Territory, and Schering
shall not distribute products that contain the same functions and
capabilities of the Product and are directly competitive with the
Product in the Territory. Subject to the provisions of this
Agreement, Digital Angel also shall not create or enter into a
contract to create a database that is similar to the
Database. Schering and Digital Angel shall discuss in good
faith entering into supply and distribution arrangements with
respect to the Product in other geographic markets in the
future.
8
3.02
Additional Rights
.
(a)
Digital Angel hereby grants
exclusive distribution rights to Schering for the Products in the
Companion Animal Market in the Territory. With respect to
those countries listed on Exhibit C or animal species not included
in the Territory, nothing herein shall be deemed to preclude
Schering from marketing products in such countries directly
competitive with the Products. Digital Angel and Schering
shall discuss potential distribution, co-marketing agreements,
amendments or renewals of existing distribution or co-marketing
agreements with respect to the Products in international markets
and companion animal species prior to executing an agreement,
amendment or renewal with a competitor of either Party.
(b)
Digital Angel shall use its
reasonable efforts to cause its Affiliate to grant an exclusive
option to Schering or its Affiliate during the Term of this
Agreement to enter into an exclusive license agreement, upon terms
and conditions to be negotiated by the parties and subject to any
contractual obligations in effect as of the date of this Agreement,
with respect to applications of the Products in the human
pharmaceutical or medical device market.
3.03
Forecasts .
(a)
Schering shall, within two (2)
months from the Effective Date, and not later than sixty (60) days
prior to the commencement of each calendar quarter thereafter
during the Term, submit to Digital Angel a written, good-faith and
non-binding forecast of Schering’s requirements for the
Product for each of the succeeding twelve (12) calendar months
after the date of such forecast. Schering shall have the
right, not later than ninety (90) days prior to the commencement of
any calendar month, to revise its forecast for such month.
All estimates shall be prepared in good faith in order to
facilitate Digital Angel’s efficient manufacture and shipment
of the Product in compliance with this Agreement, and except as
provided in Section 3.03(b) hereof, shall not be binding upon
Schering in any way. Schering shall not be responsible for
any loss, cost, or expense of Digital Angel arising from any such
forecast. The Parties acknowledge and agree that any forecast shall
not constitute, or be deemed to constitute, a commitment on the
part of Schering to submit any purchase orders or to purchase any
quantity of Products.
(b)
Schering shall submit to Digital
Angel a non cancelable purchase order for the Product not less than
ninety (90) days prior to the delivery date requested by Schering
in such purchase order. Each purchase order shall (i) be in
an amount not greater than one hundred twenty-five percent (125%)
of the latest monthly forecast submitted by Schering pursuant to
Section 3.03(a) hereof and (ii) set forth the quantity of the
Product, the date by which such Product is to be delivered, and the
destination where such order of Product is to be delivered in the
Territory. Digital Angel shall, within ninety (90) days from
the date of receipt of a purchase order (or at such later date as
may be requested in such purchase order) and subject to
Section 12.02 hereof, diligently complete and ship (or cause
to be diligently completed and shipped) such purchase order.
The provisions of this Agreement shall apply to, and form part of,
any and all purchase orders which may be submitted by Schering to
Digital Angel during the Term. The terms of this Agreement shall be
controlling over the terms and conditions set forth on any purchase
order, any acknowledgement form of Digital Angel, invoice, or other
form or document of either Party.
c)
Shering shall have the right to send
written notice to Digital Angel of any reduction, suspension or
hold upon any purchase order in whole or in part, and Digital Angel
shall use its best efforts to reschedule such purchase orders
as requested.
9
3.04
Purchase Targets
.
(a)
During the Term of the Agreement,
Schering shall, by the end of calendar year 2006, shall have
purchased twenty percent (20%) more than the amount of Product
purchased in calendar year 2005. Schering shall, by the end of
calendar year 2005, have purchased twenty percent (20%) more than
the amount of Product purchased in calendar year 2004.
(b)
On the second anniversary of the
Effective Date, the Parties shall negotiate new purchase targets
for the Product for calendar year 2007 through year 2008. On
the fourth anniversary of the Effective Date, the Parties shall
negotiate new purchase targets for the Product for calendar year
2009 through the end of the Term. If the Parties cannot agree
upon the purchase targets, the Parties shall have a meeting with
senior executives of each Party. If the Parties still are
unable to agree upon the purchase targets, the Parties shall retain
a neutral third party to determine the purchase targets. The
purchase targets may be calculated annually or averaged over a two
(2) year period.
(c)
If Schering is unable to meet its
purchase targets for more than one (1) calendar year, Schering and
Digital Angel shall meet to renegotiate purchase targets. If
Schering is unable to meet its revised purchase targets for more
than two (2) consecutive calendar years, Schering shall purchase
from Ditigal Angel the sufficient amount of Product set forth in
the purchase targets applicable to such years and during each
succeeding year. If Schering fails to make such purchases of
Product, Digital Angel may terminate the Agreement in accordance
with Section 10.05(b).
3.05
Delay and Failure to
Supply.
(a)
If Digital Angel, at any time during
the Term, has reason to believe that it will be unable to meet
Schering’s requested delivery dates, then Digital Angel shall
promptly notify Schering, stating the reason(s) for the
delay. Compliance by Digital Angel with this
Section 3.05(a) shall not relieve, or be deemed to relieve,
Digital Angel of any other obligation or liability under this
Agreement.
(b)
In the event Digital Angel fails,
for any reason (except any delay or failure of performance in
accordance with Section 12.02 hereof), to supply at least
ninety percent (90%) of any purchase order for the Product
submitted in accordance with Section 3.03(b) hereof within
ninety (90) days from the delivery date requested in such purchase
order, Schering shall have the right, upon written notice to
Digital Angel, to seek and establish a secondary source of supply
for the purchase requirements pursuant to Section 3.03(b)
hereof. Further, the first time Digital Angel fails to supply
at least ninety percent (90%) of a purchase order for the Product,
Schering shall receive a five percent (5%) discount on the purchase
price for such purchase order; the second time, Schering shall
receive a ten percent (10%) discount; the third time, Schering
shall receive a fifteen percent (15%) discount; the fourth time,
Schering shall receive a twenty percent (20%) discount; and the
fifth and any subsequent times, Schering shall receive a
twenty-five percent (25%) discount.
10
(c)
In the event Schering determines or
believes, in good faith as to any calendar quarter, that Digital
Angel, for any reason (excluding any delay or failure of
performance in accordance with Section 12.02 hereof), cannot
satisfy Schering’s purchase order requirements for the
Product, Schering shall have the right to request that Digital
Angel provide written assurance of its future performance and
ability to supply Schering not less than ninety-five percent (95%)
of any purchase order delivered in accordance with this
Agreement. Digital Angel shall, within ten (10) days from the
date of receipt of such request, provide to Schering such
assurance. If (i) Digital Angel fails to provide such
assurance within such ten (10)-day period, or (ii) Digital Angel
fails to adhere to or otherwise comply with such assurance, , then
Schering shall, in addition to any rights and remedies available to
it under this Agreement, have the right to terminate this
Agreement.
(d)
In the event Digital Angel
determines that it, for any reason (excluding any delay or failure
of performance in accordance with Section 12.02 hereof), will
not be able to supply (i) Schering’s purchase orders for the
Product or (ii) at least ninety-five percent (95%) of any purchase
order for the Product submitted in accordance with
Section 3.03(b) hereof on the delivery date requested in such
purchase order, Digital Angel shall, within two (2) days from the
date of such determination, notify Schering of such determination,
and Schering shall have the right to suspend this Agreement and to
seek and establish another source of supply for the purchase of the
shortfall of the Products, but Schering shall have no right to
grant a license to any third party to develop or manufacturer any
product that is similar to or competitive with the Product.
Digital Angel shall immediately notify Schering when and if Digital
Angel is able to resume supply of the Product in accordance with
the terms of this Agreement, and the Parties shall meet promptly to
determine the terms and conditions upon which Digital Angel shall
supply the Product, including, without limitation, written
assurance of its future performance and ability to supply the
Product. If Digital Angel does not meet the delivery date set
forth in the purchase order and has failed to notify Schering in
accordance with this Section 3.05(d), then Schering may
terminate this Agreement upon written notice to Digital
Angel.
3.06
Quality Control
.
(a)
Manufacture of the
Product . Digital
Angel represents, warrants, and covenants that all Product for or
sold to Schering pursuant to this Agreement shall: (i) be
manufactured, packaged, and labeled in accordance with the
Specifications, Applicable Laws, and the terms of this Agreement;
(ii) be free of all defects and deleterious materials; (iii) not
be, or deemed to be, adulterated or misbranded within the meaning
of any Applicable Law. (iv) be manufactured, packaged, and tested
to ensure that the Product meets the Specifications for identity,
sterility, quality, and stability; (v) be manufactured in
accordance with the quality control program which Digital Angel
shall maintain during the Term; (vi) bear a true and accurate
expiration date; (vii) have, as of the date of receipt of such
Product at the facility of Schering, a remaining shelf life not
less than ninety-five percent (95%) of the total stated shelf life
of such Product; and (viii) may be introduced into interstate
commerce pursuant to Applicable Laws.
(b)
Change in Materials
. Digital Angel shall give
Schering ninety (90) days prior written notice, if reasonably
possible, in the event Digital Angel changes or causes to
be
11
changed any materials, equipment, or method of
production or testing relating to the Product, which directly
relate to the efficacy of the Product; provided ,
however , that any such change shall also comply in all
respects with the Specifications and Applicable Laws. Digital
Angel shall provide any additional information regarding such
change as Schering shall request.
(c)
Certificate
. Digital Angel shall, prior
to the loading of each shipment of the Product, (i) test and
analyze or cause or to be tested and analyzed (by a laboratory
approved by Schering) such shipment and (ii) deliver or cause to be
delivered to Schering or any Person designated by Schering a
certificate of weight and quality analysis, in a form satisfactory
to Schering (“Certificate”), which Certificate shall
provide that such shipment conforms to the Specifications,
Applicable Laws and the purchase order.
(d)
Testing of Shipment
.
(i)
Schering shall have the right,
within thirty (30) days from the date of receipt of a Certificate
or the delivery of a shipment of the Product relating to such
Certificate at its proper destination, whichever is later, to
determine (through testing or analysis approved in accordance with
this Agreement) the conformity of the contents and the weight of
such shipment to the warranties set forth in Section 3.06(a)
hereof, including, without limitation, the Certificate and the
Specifications.
(ii)
The Parties agree that the testing
or analysis to determine the conformity of the contents of a
shipment of the Product to the Certificate and the Specifications
may be performed either by Schering or by an independent laboratory
selected by Schering. In the event the contents of any
shipment of the Product do not conform to the warranties set forth
in Section 3.06(a) hereof, including, without limitation, the
Certificate or the Specifications as determined by such laboratory,
Schering shall submit a copy of such determination to Digital
Angel, and Digital Angel shall, at Digital Angel’s discretion
and Digital Angel’s cost and expense, (A) replace (at no cost
or expense to Schering) any shipment of the Product rejected by
Schering or (B) refund to Schering any amount paid to Digital Angel
by Schering for any such shipment. Upon demand by Schering,
Digital Angel shall reimburse or credit Schering for all costs and
expenses incurred by Schering with respect to the non-conforming
Product, which costs and expenses shall include, without
limitation, all testing, analysis, transportation, insurance and
holding charges incurred in connection with such Product.
Digital Angel shall maintain sufficient inventory to replace all
non-conforming Product rejected by Schering. The Parties
acknowledge and agree that Schering shall have no obligation to pay
any invoice for any shipment of the Product rejected in accordance
with this Section 3.06, unless replacement Product is provided
to Schering by Digital Angel. Conformance of the content of a
shipment to the applicable Certificate and the Specifications shall
be deemed to be a material obligation of this Agreement. The rights
and remedies set forth in this Section 3.06(d)(ii) shall be in
addition to any other rights and remedies that Schering may have
hereunder or at law or equity.
(e)
Document and Reserve Sample
Retention .
(i)
All documents, records and reports
associated with the manufacture, holding, storage, packaging or
testing of any Product shall be retained by Digital Angel for not
less than five (5) years from the date of manufacture, or as
otherwise directed by
12
Schering. All such documents, records and
reports must be prepared and retained by Digital Angel in such a
manner that they are (A) readily retrievable and (B) stored in an
environment suitable to prevent damage or loss.